MC

502.4

-1.14%↓

SANES

6.895

+0.23%↑

BNP

78.98

-1.08%↓

BBVA

13.375

+0.22%↑

INGA

18.908

+0.06%↑

MC

502.4

-1.14%↓

SANES

6.895

+0.23%↑

BNP

78.98

-1.08%↓

BBVA

13.375

+0.22%↑

INGA

18.908

+0.06%↑

MC

502.4

-1.14%↓

SANES

6.895

+0.23%↑

BNP

78.98

-1.08%↓

BBVA

13.375

+0.22%↑

INGA

18.908

+0.06%↑

MC

502.4

-1.14%↓

SANES

6.895

+0.23%↑

BNP

78.98

-1.08%↓

BBVA

13.375

+0.22%↑

INGA

18.908

+0.06%↑

MC

502.4

-1.14%↓

SANES

6.895

+0.23%↑

BNP

78.98

-1.08%↓

BBVA

13.375

+0.22%↑

INGA

18.908

+0.06%↑

Search

Gimv NV

Закрыт

СекторФинансы

43.05 0.58

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

42.5

Макс.

43.3

Ключевые показатели

By Trading Economics

Доход

145M

Продажи

187M

P/E

Средняя по отрасли

6.003

24.598

Дивидендная доходность

6.09

Рентабельность продаж

77.344

Сотрудники

93

EBITDA

146M

Дивиденды

By Dow Jones

Дивидендная доходность

Средняя по отрасли

6.09%

4.30%

Следующий отчет о доходах

22 мая 2025 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

1.5B

Предыдущая цена открытия

42.47

Предыдущая цена закрытия

43.05

Новостные настроения

By Acuity

21%

79%

46 / 540 Рейтинг в Finance

Gimv NV График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

14 мая 2025 г., 23:40 UTC

Популярные акции

Stocks to Watch: UnitedHealth Group, Foot Locker, CoreWeave

14 мая 2025 г., 23:33 UTC

Главные движущие силы рынка

UnitedHealth Group Shares Fall After WSJ Reports of Investigation for Possible Medicare Fraud

14 мая 2025 г., 23:25 UTC

Главные движущие силы рынка

Biohaven Shares Down as FDA Extends PDUFA Data for Troriluzole

14 мая 2025 г., 23:25 UTC

Отчет

Xero Lifts Fiscal Year Profit 30% on Higher Prices, Subscriber Growth -- Update

14 мая 2025 г., 22:58 UTC

Отчет

Xero Lifts Fiscal Year Profit 30% on Higher Prices, Subscriber Growth

14 мая 2025 г., 21:35 UTC

Отчет

Cisco Systems Names Patterson as CFO, Patel as President

14 мая 2025 г., 23:59 UTC

Обсуждения рынка

Implications of Xero's Cost Outlook Aren't Clear -- Market Talk

14 мая 2025 г., 23:49 UTC

Обсуждения рынка

Xero's Cost Outlook Likely to Prompt Downgrades -- Market Talk

14 мая 2025 г., 23:48 UTC

Обсуждения рынка

Global Equities Roundup: Market Talk

14 мая 2025 г., 23:48 UTC

Обсуждения рынка

Nikkei May Decline on Profit-Taking After Recent Gains -- Market Talk

14 мая 2025 г., 23:47 UTC

Обсуждения рынка

Gold Gains on Possible Technical Recovery -- Market Talk

14 мая 2025 г., 23:34 UTC

Приобретения, слияния, поглощения

Agnico-Eagle Mines to Subscribe for 30M Voting Common Shares of Foran Mining in Non-Brokered Private Placement at C$3 a Share

14 мая 2025 г., 23:10 UTC

Отчет

Xero Lifts FY Profit 30% on Higher Prices, Subscriber Growth -- Update

14 мая 2025 г., 23:07 UTC

Отчет

CoreWeave Posts Strong Revenue and Wins Google as a Customer. Stock Still Dives on Outlook. -- Barrons.com

14 мая 2025 г., 23:00 UTC

Главные новости

UnitedHealth Group Is Under Criminal Investigation for Possible Medicare Fraud -- WSJ

14 мая 2025 г., 22:43 UTC

Отчет

Xero Lifts FY Profit 30% on Higher Prices, Subscriber Growth

14 мая 2025 г., 22:34 UTC

Отчет

Xero Expects 1H Operating Expense Ratio to Be Higher Than 2H>XRO.AU

14 мая 2025 г., 22:33 UTC

Отчет

Xero Expects FY26 Operating Expense Ratio of 71.5%>XRO.AU

14 мая 2025 г., 22:30 UTC

Отчет

Xero Did Not Declare a Dividend>XRO.AU

14 мая 2025 г., 22:30 UTC

Отчет

Xero FY Operating Expenses 71.8% of Operating Revenue Vs. 73.3%>XRO.AU

14 мая 2025 г., 22:30 UTC

Отчет

Xero FY Free Cashflow Margin 24.1% Vs. 20.0%>XRO.AU

14 мая 2025 г., 22:30 UTC

Отчет

Xero FY Free Cashflow NZD506.7M Vs. NZD342.1M>XRO.AU

14 мая 2025 г., 22:28 UTC

Отчет

Xero FY Ebitda NZD638.5M Vs. NZD497.4M>XRO.AU

14 мая 2025 г., 22:28 UTC

Отчет

Xero FY Adjusted Ebitda NZD640.6M Vs. NZD526.5M>XRO.AU

14 мая 2025 г., 22:27 UTC

Отчет

Xero FY Rev NZD2.10B Vs. NZD1.71B >XRO.AU

14 мая 2025 г., 22:27 UTC

Отчет

Xero FY Net NZD227.8M Vs. Net NZD174.6M >XRO.AU

14 мая 2025 г., 22:23 UTC

Главные новости

Boeing, GE Aerospace Get Qatar Airways Order After Saudi AI Tech Deals -- 2nd Update

14 мая 2025 г., 22:15 UTC

Отчет

Correction to Cisco Earnings Article -- WSJ

14 мая 2025 г., 21:48 UTC

Отчет

CoreWeave Posts Strong Revenue but Stock Dives on Updated Outlook -- Barrons.com

14 мая 2025 г., 21:37 UTC

Отчет

Cisco Reports Solid Earnings. The Stock Is Rising. -- Barrons.com

Сравнение c конкурентами

Изменение цены

Gimv NV Прогноз

Консенсус по рейтингу

By TipRanks

0 ratings

0

Покупка

0

Удержание

0

Продажа

Настроения

By Acuity

46 / 540Рейтинг в Финансы

Новостные настроения

Сильные свидетельства восходящего тренда

Волатильность

Ниже среднего

Объем новостей (RCV)

Средняя

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Gimv NV

Gimv NV is a private equity and venture capital firm specializing in direct and fund of funds investments. For direct investments, the firm specializes in buyouts, growth capital, middle market, debt, shareholder loans, seed, startups, early to mid-stage, late venture, public to private transactions, small and medium sized enterprises, later stage, mature, replacement capital, bridge financing, and recapitalization. Within fund of funds, it seeks to invest in venture capital and private equity funds. It seeks to invest in high performance growth companies that respond to that can speed up their internal growth through acquisitions. The firm typically invests in consumer, connected consumer, fintech; health and care; smart industries; and sustainable cities. Within consumer, it seeks to provide growth capital to emerging leaders. Within health and care platform, the firm seeks to invest in companies that can grow either organically or through a buy and build strategy. Within consumer, it focuses on consumer goods, food and beverage, healthy food, sport, convenience food, personal luxury, career, home & deco, baby & kids, pet products, retail, consumer services, media and content, travel and leisure, education, digital economy and online sectors. Within health and care sector, it focuses on life sciences, medtech, and health and care services. The firm focuses on biotech/biopharma comprising drugs, platform technologies, vaccines and diagnostic tests, preclinical, early clinical, and late clinical, medtech such as medical devices, consumables, IT and small equipment, and health and care services-based companies. It also seeks to be an active shareholder, preferably lead or co-lead in its investments. Within smart industries, it focuses on equipment, services and tools for resource efficient development and production, automotive and aerospace, both optimizing of the existing and development of new means of transport, software and services harnessing the flexibility of the cloud, smart data management and advanced c